Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
Current Hematologic Malignancy Reports|April 20, 2021
Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple MyelomaNaimisha Marneni, Rajshekhar ChakrabortyExpert Opinion on Emerging Drugs|August 1, 2020
Emerging drugs for the treatment of light chain amyloidosisRajshekhar Chakraborty, Suzanne LentzschAmerican Journal of Hematology|February 23, 2020
Treatment and disease-related complications in multiple myeloma: Implications for survivorshipRajshekhar Chakraborty, Navneet S MajhailBlood|January 20, 2026
Time to Revise Myeloma Diagnostic Criteria? A Decade of Accumulated Evidence on Serum Free Light Chain Ratio ≥100Rajshekhar Chakraborty, Ghulam Rehman MohyuddinHematology. American Society of Hematology. Education Program|December 5, 2025
Endless possibilities and how to exploit them? What is the optimal treatment sequence?Rajshekhar Chakraborty, Divaya Bhutani, Suzanne LentzschBritish Journal of Haematology|May 22, 2023
How do we image patients with multiple myeloma and precursor states?Rajshekhar Chakraborty, Jens Hillengass, Suzanne LentzschBritish Journal of Haematology|May 20, 2022
How do we manage t(11;14) plasma cell disorders with venetoclax?Rajshekhar Chakraborty, Divaya Bhutani, Suzanne LentzschCurrent Heart Failure Reports|August 8, 2016
Newer Therapies for Amyloid CardiomyopathyRajshekhar Chakraborty, Eli Muchtar, Morie A GertzAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 11, 2026
Management of Bispecific Antibody Toxicities: A Focus on Multiple MyelomaEden Biltibo, Rajshekhar Chakraborty, Michael R BishopBest Practice & Research. Clinical Haematology|November 10, 2016
The role of stem cell transplantation in Waldenstrom's macroglobulinemiaRajshekhar Chakraborty, Eli Muchtar, Morie A GertzPageof 10